Reactivation of latent hepatitis B infection during immunosuppressive therapy with guselkumab for plaque psoriasis: a case report

Reactivation of hepatitis B virus (HBV; RHBV) is a significant concern during immunosuppressive therapy, as it can lead to severe hepatitis and liver failure. The article reports a case of RHBV during treatment with guselkumab, an interleukin-23 inhibitor in a patient with inactive HBV infection and...

Full description

Saved in:
Bibliographic Details
Main Authors: Elena Franchi, Arianna A. C. Costanzo, Carmela Cursaro, Amedeo Lonardo, Claudia Lasagni, Pietro Andreone
Format: Article
Language:English
Published: Open Exploration 2023-12-01
Series:Exploration of Drug Science
Subjects:
Online Access:https://www.explorationpub.com/uploads/Article/A100831/100831.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1825199594079780864
author Elena Franchi
Arianna A. C. Costanzo
Carmela Cursaro
Amedeo Lonardo
Claudia Lasagni
Pietro Andreone
author_facet Elena Franchi
Arianna A. C. Costanzo
Carmela Cursaro
Amedeo Lonardo
Claudia Lasagni
Pietro Andreone
author_sort Elena Franchi
collection DOAJ
description Reactivation of hepatitis B virus (HBV; RHBV) is a significant concern during immunosuppressive therapy, as it can lead to severe hepatitis and liver failure. The article reports a case of RHBV during treatment with guselkumab, an interleukin-23 inhibitor in a patient with inactive HBV infection and psoriasis. This report highlights the importance of screening for HBV prior to immunosuppressive therapy and initiating prophylactic therapy when necessary to prevent reactivation and its complications.
format Article
id doaj-art-a6d5de978c0540729b1f7f1da45e40b8
institution Kabale University
issn 2836-7677
language English
publishDate 2023-12-01
publisher Open Exploration
record_format Article
series Exploration of Drug Science
spelling doaj-art-a6d5de978c0540729b1f7f1da45e40b82025-02-08T03:44:56ZengOpen ExplorationExploration of Drug Science2836-76772023-12-011646847410.37349/eds.2023.00031Reactivation of latent hepatitis B infection during immunosuppressive therapy with guselkumab for plaque psoriasis: a case reportElena Franchi0https://orcid.org/0000-0001-6217-2914Arianna A. C. Costanzo1Carmela Cursaro2https://orcid.org/0000-0002-5644-2508Amedeo Lonardo3https://orcid.org/0000-0001-9886-0698Claudia Lasagni4Pietro Andreone5https://orcid.org/0000-0002-4794-9809Postgraduate school of Internal Medicine, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, Ospedale Civile di Baggiovara, 41126 Modena, ItalyPostgraduate school of Internal Medicine, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, Ospedale Civile di Baggiovara, 41126 Modena, ItalyDepartment of Internal Medicine, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, Ospedale Civile di Baggiovara, 41126 Modena, ItalyDepartment of Internal Medicine, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, Ospedale Civile di Baggiovara, 41126 Modena, ItalyDepartment of Dermatology, Head and Neck Skin Cancer Service, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, Ospedale Civile di Baggiovara, 41126 Modena, ItalyDepartment of Internal Medicine and Chief of postgraduate school of Allergy and Clinical Immunology, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, Ospedale Civile di Baggiovara, 41126 Modena, ItalyReactivation of hepatitis B virus (HBV; RHBV) is a significant concern during immunosuppressive therapy, as it can lead to severe hepatitis and liver failure. The article reports a case of RHBV during treatment with guselkumab, an interleukin-23 inhibitor in a patient with inactive HBV infection and psoriasis. This report highlights the importance of screening for HBV prior to immunosuppressive therapy and initiating prophylactic therapy when necessary to prevent reactivation and its complications.https://www.explorationpub.com/uploads/Article/A100831/100831.pdfhepatitis b infectionreactivationguselkumabpsoriasis
spellingShingle Elena Franchi
Arianna A. C. Costanzo
Carmela Cursaro
Amedeo Lonardo
Claudia Lasagni
Pietro Andreone
Reactivation of latent hepatitis B infection during immunosuppressive therapy with guselkumab for plaque psoriasis: a case report
Exploration of Drug Science
hepatitis b infection
reactivation
guselkumab
psoriasis
title Reactivation of latent hepatitis B infection during immunosuppressive therapy with guselkumab for plaque psoriasis: a case report
title_full Reactivation of latent hepatitis B infection during immunosuppressive therapy with guselkumab for plaque psoriasis: a case report
title_fullStr Reactivation of latent hepatitis B infection during immunosuppressive therapy with guselkumab for plaque psoriasis: a case report
title_full_unstemmed Reactivation of latent hepatitis B infection during immunosuppressive therapy with guselkumab for plaque psoriasis: a case report
title_short Reactivation of latent hepatitis B infection during immunosuppressive therapy with guselkumab for plaque psoriasis: a case report
title_sort reactivation of latent hepatitis b infection during immunosuppressive therapy with guselkumab for plaque psoriasis a case report
topic hepatitis b infection
reactivation
guselkumab
psoriasis
url https://www.explorationpub.com/uploads/Article/A100831/100831.pdf
work_keys_str_mv AT elenafranchi reactivationoflatenthepatitisbinfectionduringimmunosuppressivetherapywithguselkumabforplaquepsoriasisacasereport
AT ariannaaccostanzo reactivationoflatenthepatitisbinfectionduringimmunosuppressivetherapywithguselkumabforplaquepsoriasisacasereport
AT carmelacursaro reactivationoflatenthepatitisbinfectionduringimmunosuppressivetherapywithguselkumabforplaquepsoriasisacasereport
AT amedeolonardo reactivationoflatenthepatitisbinfectionduringimmunosuppressivetherapywithguselkumabforplaquepsoriasisacasereport
AT claudialasagni reactivationoflatenthepatitisbinfectionduringimmunosuppressivetherapywithguselkumabforplaquepsoriasisacasereport
AT pietroandreone reactivationoflatenthepatitisbinfectionduringimmunosuppressivetherapywithguselkumabforplaquepsoriasisacasereport